1911 — China Renaissance Holdings Share News
0.000.00%
Last trade - 00:00- HK$1.90bn
- -HK$1.62bn
- CNY1.20bn
Innovent Biologics set for biggest jump in 5 months on FY revenue growth
Brief: China Renaissance Expects FY Profit Attributable RMB101.4 Mln
Chinese hypermarket giant Sun Art says it lost contact with CEO (updated)
Brief: China Renaissance Buys Distressed Assets Portfolio I For Rmb277.1 Million
Innovent Biologics climbs on inclusion in Hang Seng Index
Media: China Renaissance seeks $600 million for BNB crypto treasury - Bloomberg News
Brief: China Renaissance Announces MoU With Yzi Labs
Brief: China Renaissance Expects RMB64.98 Million Profit For HY
High-profile Chinese dealmaker Bao Fan released from detention after two years, source says (updated)
China Renaissance founder Bao Fan released, Caixin reports (updated)
China Renaissance founder Bao Fan 'released', Caixin reports
Brief: China Renaissance Budgets $100 Mln Over Next Two Years To Develop Web3.0 Business
Innovent Biologics rises on robust Q1 product revenue growth
Brief: China Renaissance Says Loss For Year Attributable RMB179.0 Million
Innovent Biologics rises as regulator approves co's product for cancer treatment
Moves: Jefferies appoints Jason Lam from China Renaissance as Asia TMT investment banking head
Brief: China Renaissance Says Wang Lixing Appointed As CEO
Brief: China Renaissance Hui Yin Ching Appointed As Chairperson
Brief: China Renaissance Says Lam Ka Cheong Jason Resigned As Executive Director